BioCryst to Present at Upcoming Investor Conferences
BioCryst Pharmaceuticals (NASDAQ: BCRX) has announced its participation in two major upcoming investor conferences. The company will present at the Jefferies Global Healthcare Conference in New York on June 4, 2025, at 4:55 p.m. ET, and at the Goldman Sachs 46th Annual Global Healthcare Conference in Miami on June 9, 2025, at 8:40 a.m. ET. Investors can access live audio webcasts and replays of both presentations through the Investors & Media section of BioCryst's website.
BioCryst Pharmaceuticals (NASDAQ: BCRX) ha annunciato la sua partecipazione a due importanti conferenze per investitori in programma. L'azienda presenterà alla Jefferies Global Healthcare Conference a New York il 4 giugno 2025 alle 16:55 ET, e alla Goldman Sachs 46th Annual Global Healthcare Conference a Miami il 9 giugno 2025 alle 8:40 ET. Gli investitori potranno seguire le presentazioni in diretta audio streaming e rivederle successivamente nella sezione Investors & Media del sito di BioCryst.
BioCryst Pharmaceuticals (NASDAQ: BCRX) ha anunciado su participación en dos importantes conferencias para inversores próximamente. La compañía presentará en la Jefferies Global Healthcare Conference en Nueva York el 4 de junio de 2025 a las 4:55 p.m. ET, y en la Goldman Sachs 46th Annual Global Healthcare Conference en Miami el 9 de junio de 2025 a las 8:40 a.m. ET. Los inversores podrán acceder a transmisiones de audio en vivo y repeticiones de ambas presentaciones a través de la sección Investors & Media en el sitio web de BioCryst.
BioCryst Pharmaceuticals (NASDAQ: BCRX)가 다가오는 두 주요 투자자 컨퍼런스에 참가할 예정임을 발표했습니다. 회사는 2025년 6월 4일 오후 4시 55분(동부시간)에 뉴욕에서 열리는 Jefferies Global Healthcare Conference와 2025년 6월 9일 오전 8시 40분(동부시간)에 마이애미에서 개최되는 Goldman Sachs 46th Annual Global Healthcare Conference에서 발표할 예정입니다. 투자자들은 BioCryst 웹사이트의 Investors & Media 섹션을 통해 두 발표의 실시간 오디오 웹캐스트와 다시보기를 이용할 수 있습니다.
BioCryst Pharmaceuticals (NASDAQ : BCRX) a annoncé sa participation à deux grandes conférences d'investisseurs à venir. La société présentera lors de la Jefferies Global Healthcare Conference à New York le 4 juin 2025 à 16h55 ET, ainsi qu'à la Goldman Sachs 46th Annual Global Healthcare Conference à Miami le 9 juin 2025 à 8h40 ET. Les investisseurs pourront accéder aux webcasts audio en direct et aux replays des deux présentations via la section Investors & Media du site web de BioCryst.
BioCryst Pharmaceuticals (NASDAQ: BCRX) hat seine Teilnahme an zwei bedeutenden bevorstehenden Investorenkonferenzen bekannt gegeben. Das Unternehmen wird auf der Jefferies Global Healthcare Conference in New York am 4. Juni 2025 um 16:55 Uhr ET sowie auf der Goldman Sachs 46th Annual Global Healthcare Conference in Miami am 9. Juni 2025 um 8:40 Uhr ET präsentieren. Investoren können Live-Audio-Webcasts und Aufzeichnungen beider Präsentationen über den Bereich Investors & Media auf der Website von BioCryst abrufen.
- None.
- None.
RESEARCH TRIANGLE PARK, N.C., May 27, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the following conferences:
- Jefferies Global Healthcare Conference in New York on Wednesday, June 4, 2025, at 4:55 p.m. ET.
- Goldman Sachs 46th Annual Global Healthcare Conference in Miami on Monday, June 9, 2025, at 8:40 a.m. ET.
Links to the live audio webcasts and replays of the presentations may be accessed in the Investors & Media section of BioCryst’s website at www.biocryst.com.
About BioCryst Pharmaceuticals
BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema and other rare diseases. BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn.
BCRXW
Contact:
John Bluth
+1 919 859 7910
jbluth@biocryst.com
FAQ
When is BioCryst (BCRX) presenting at the Jefferies Global Healthcare Conference 2025?
What time is BioCryst's presentation at the Goldman Sachs Healthcare Conference 2025?
How can investors access BioCryst's (BCRX) conference presentations?
Which investor conferences is BioCryst (BCRX) attending in June 2025?
